Výsledky vyhledávání - "Pacey, M. S."

Akademický článek

Biotransformation of selamectin with Streptomyces lydicus SX-1298 using a novel static agar fermentation system with Reemay mesh.

Autor: Pacey MS; Veterinary Medicine Discovery, Pfizer Global Research and Development, Sandwich, Kent, UK. mike_pacey@sandwich.pfizer.com, Barnes MM, Monday RA, Ritzau M, Wellington EM

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 2001 May; Vol. 54 (5), pp. 448-54.

Zobrazit plný text záznamu

Akademický článek

Avermectins and flea control: structure-activity relationships and the selection of selamectin for development as an endectocide for companion animals.

Autor: Banks BJ; Pfizer Central Research, Sandwich, Kent, UK. bernard_banks@sandwich.pfizer.com, Bishop BF, Evans NA, Gibson SP, Goudie AC, Gration KA, Pacey MS, Perry DA, Witty MJ

Publikováno v: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2000 Aug; Vol. 8 (8), pp. 2017-25.

Zobrazit plný text záznamu

Akademický článek

Preparation of 13-epi-selamectin by biotransformation using a blocked mutant of Streptomyces avermitilis.

Autor: Pacey MS; Animal Health Central Research, Pfizer Central Research, Sandwich, Kent, UK., Dutton CJ, Monday RA, Ruddock JC, Smith GC

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 2000 Mar; Vol. 53 (3), pp. 301-5.

Zobrazit plný text záznamu

Akademický článek

Structural elucidation of a novel erythromycin, 13-cyclopentyl-13-desethyl-erythromycin B, from a recombinant Saccharopolyspora erythraea strain, NRRL 2338 pIG/1.

Autor: Parsons IC; Department of Physical Sciences, Pfizer Central Research, Sandwich, Kent, UK., Everett JR, Pacey MS, Ruddock JC, Swanson AG, Thompson CM

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 1999 Feb; Vol. 52 (2), pp. 190-2.

Zobrazit plný text záznamu

Akademický článek

Novel erythromycins from a recombinant Saccharopolyspora erythraea strain NRRL 2338 pIG1. I. Fermentation, isolation and biological activity.

Autor: Pacey MS; Animal Health Central Research, Pfizer Central Research, Sandwich, Kent, UK., Dirlam JP, Geldart RW, Leadlay PF, McArthur HA, McCormick EL, Monday RA, O'Connell TN, Staunton J, Winchester TJ

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 1998 Nov; Vol. 51 (11), pp. 1029-34.

Zobrazit plný text záznamu

Akademický článek

C-13 beta-acyloxymilbemycins, a new family of macrolides. Discovery, structural determination and biological properties.

Autor: Haxell MA; Central Research Division, Pfizer Ltd., Sandwich, Kent, England., Bishop BF, Bryce P, Gration KA, Kara H, Monday RA, Pacey MS, Perry DA, Kojima Y, Maeda H, et. al.

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 1992 May; Vol. 45 (5), pp. 659-70.

Zobrazit plný text záznamu

Akademický článek

Novel avermectins produced by mutational biosynthesis.

Autor: Dutton CJ; Central Research Division, Pfizer Ltd., Kent, England., Gibson SP, Goudie AC, Holdom KS, Pacey MS, Ruddock JC, Bu'Lock JD, Richards MK

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 1991 Mar; Vol. 44 (3), pp. 357-65.

Zobrazit plný text záznamu

Akademický článek

UK-69,753, a novel member of the efrotomycin family of antibiotics. I. Taxonomy of the producing organism, fermentation and isolation.

Autor: Pacey MS; Central Research Division, Pfizer Ltd., Kent, England., Jefson MR, Huang LH, Cullen WP, Maeda H, Tone J, Nishiyama S, Kaneda K, Ishiguro M

Publikováno v: The Journal of antibiotics [J Antibiot (Tokyo)] 1989 Oct; Vol. 42 (10), pp. 1453-9.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání